Big Ten Network
Features Proton Therapy
PhiladelphiaFox29 features Dr. James Metz
MDACCO in the News
Fox News Health
CBS Evening News
Proton Community Forum
New Prostate Cancer Report Commissioned by
NAPT Released at National Proton Conference in Washington, D.C.
97 Percent of Prostate Cancer Patients Treated With Proton Therapy Have Not Suffered Recurrence
Washington, D.C. (April 2, 2014) -- Approximately 97 percent of patients who received only an advanced form of radiation called proton therapy for prostate cancer report that they have not experienced a recurrence of their disease, according to a new survey of nearly 4,000 patients released today at the second annual National Proton Conference in Arlington, VA.
The National Association for Proton Therapy (NAPT) is a non-profit organization supported by proton center members and is the Voice of the Proton Community. The NAPT promotes education and public awareness for the clinical benefits of proton beam radiation therapy. Founded in 1990, NAPT is an advocate for the advancement of proton therapy. It serves as a resource center for patients, physicians and health care providers, universities, academic medical centers, hospitals, cancer centers, the Centers for Medicare and Medicaid Services (CMS) and other health care agencies, the U.S. Congress and staff, and the news media.
We are strong advocates for patient access to proton therapy as a superior form of radiation treatment for cancerous tumors that can result in less morbidity and minimum to no side effects.
Supporting operating center members:
Other operating centers:
Board of Directors: John B. Frick - ProCure Treatment Centers; Stuart Klein - University of Florida Proton Therapy Institute; Stephen Jacobs - Loma Linda University Medical Center; Fern Nibauer-Cohen - UPENN; Leonard Arzt - National Association for Proton Therapy